Press Releases Prescient Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:59 14/05/2024 BST			5-day change	1st Jan Change
0.04 ^AUD	-4.76%		-13.04%	-35.48%

03-25	Transcript : Prescient Therapeutics Limited - Special Call
02-23	Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Prescient Therapeutics showcases cell therapy data at prestigious ISCT conference	16/06/23	AQ
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100	09/03/23	AQ
Prescient Therapeutics : June 2022 Quarterly Update and Appendix 4C	24/07/22	PU
Prescient Therapeutics : Application for quotation of securities - PTX	22/07/22	PU
Prescient Therapeutics : Application for quotation of securities - PTX	16/06/22	PU
Prescient Therapeutics : March 2022 Quarterly Update and Appendix 4C	29/04/22	PU
Prescient Therapeutics : Application for quotation of securities - PTX	06/04/22	PU
Prescient Therapeutics : Application for quotation of securities - PTX	07/12/21	PU
Prescient Therapeutics : Application for quotation of securities - PTX	30/11/21	PU
Prescient Therapeutics : March 2019 Appendix 4C - Quarterly	24/04/19	PU
Prescient Therapeutics : Notice of General Meeting/Proxy Form	27/03/19	PU
Prescient Therapeutics : Amended Appendix 3B - Rights Issue	27/03/19	PU
Prescient Therapeutics : Letter to Optionholders	24/03/19	PU
Prescient Therapeutics : Letter to Ineligible Shareholders	24/03/19	PU
Prescient Therapeutics : Letter to Eligible Shareholders	24/03/19	PU
Prescient Therapeutics : Appendix 3B - Rights Issue	24/03/19	PU
Prescient Therapeutics : Prospectus	24/03/19	PU
Prescient Therapeutics : Capital Raising Presentation - March 2019	24/03/19	PU
Prescient Therapeutics : Completes Equity Raising to Raise $9.1 Million	24/03/19	PU
Prescient Therapeutics : Investor Presentation - February 2019	24/02/19	PU

No results for this search